PL4023651T3 - Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca - Google Patents

Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca

Info

Publication number
PL4023651T3
PL4023651T3 PL22153273.2T PL22153273T PL4023651T3 PL 4023651 T3 PL4023651 T3 PL 4023651T3 PL 22153273 T PL22153273 T PL 22153273T PL 4023651 T3 PL4023651 T3 PL 4023651T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
same
optically active
phenol derivative
pyranochromenyl phenol
Prior art date
Application number
PL22153273.2T
Other languages
English (en)
Inventor
Sang Ku Yoo
Jin Wook Chung
In Geun Jo
Ji Young Kim
Jeong Ho Lim
Ku Suk Kang
Jin Young Kim
Original Assignee
Glaceum, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaceum, Inc. filed Critical Glaceum, Inc.
Publication of PL4023651T3 publication Critical patent/PL4023651T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL22153273.2T 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca PL4023651T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20160081674 2016-06-29

Publications (1)

Publication Number Publication Date
PL4023651T3 true PL4023651T3 (pl) 2024-02-19

Family

ID=60787377

Family Applications (2)

Application Number Title Priority Date Filing Date
PL22153273.2T PL4023651T3 (pl) 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca
PL17820539.9T PL3480200T3 (pl) 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL17820539.9T PL3480200T3 (pl) 2016-06-29 2017-06-29 Aktywna optycznie pochodna piranochromenylofenolu i kompozycja farmaceutyczna ją zawierająca

Country Status (17)

Country Link
US (2) US20190152984A1 (pl)
EP (2) EP4023651B1 (pl)
JP (2) JP2019520381A (pl)
KR (1) KR102388965B1 (pl)
CN (1) CN109476676B (pl)
AU (1) AU2017287746B2 (pl)
BR (1) BR112018077392A2 (pl)
CA (1) CA3028954C (pl)
DK (1) DK4023651T3 (pl)
ES (2) ES2964146T3 (pl)
IL (1) IL263826B2 (pl)
MX (1) MX393450B (pl)
PL (2) PL4023651T3 (pl)
SG (1) SG11201811796SA (pl)
TW (1) TWI731998B (pl)
WO (1) WO2018004263A1 (pl)
ZA (1) ZA201900121B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI641610B (zh) * 2016-10-04 2018-11-21 南韓商格雷森伍股份有限公司 用於合成3-苯基-2,3,4,8,9,10-六氫吡喃並[2,3-f]色烯衍生物及其光學異構物的方法
KR20200105198A (ko) * 2019-02-28 2020-09-07 주식회사 글라세움 신경계 질환의 예방 또는 치료용 약학적 조성물
US20250367163A1 (en) 2021-06-08 2025-12-04 Glaceum, Inc. Pharmaceutical composition for preventing or treating degenerative eye diseases
KR20240078928A (ko) * 2022-11-28 2024-06-04 가톨릭대학교 산학협력단 침샘 오가노이드 안정화 및 침샘조직 재생 유도 조성물
KR20240113389A (ko) 2023-01-12 2024-07-22 주식회사 글라세움 퇴행성 골관절염의 예방 또는 치료용 약학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050035142A (ko) * 2001-10-11 2005-04-15 카네카 코포레이션 페록시좀 증식제 응답성 수용체 리간드제 및 그 제조 방법
TW200513194A (en) * 2003-07-31 2005-04-16 Kaneka Corp Fat and oil processed composition for prevention and/or amelioration of life-style related disease
WO2007058480A1 (en) * 2005-11-16 2007-05-24 Md Bioalpha Co., Ltd. Composition having effect on treatment and prevention of diseases syndrome treatment with glabridin
KR102344479B1 (ko) * 2013-12-24 2021-12-29 주식회사 글라세움 피라노크로메닐페놀 유도체, 및 대사증후군 또는 염증 질환 치료용 약학 조성물
KR101742274B1 (ko) 2014-12-31 2017-06-01 주식회사 과학기술분석센타 소규모 상수시설 통합 관리 시스템의 수질 측정 장치
TWI641610B (zh) * 2016-10-04 2018-11-21 南韓商格雷森伍股份有限公司 用於合成3-苯基-2,3,4,8,9,10-六氫吡喃並[2,3-f]色烯衍生物及其光學異構物的方法

Also Published As

Publication number Publication date
BR112018077392A2 (pt) 2019-04-09
EP4023651A1 (en) 2022-07-06
CN109476676B (zh) 2021-09-17
EP3480200B1 (en) 2022-10-19
PL3480200T3 (pl) 2023-01-30
JP2019520381A (ja) 2019-07-18
EP3480200A4 (en) 2020-02-26
JP7036871B2 (ja) 2022-03-15
TW201808961A (zh) 2018-03-16
NZ749461A (en) 2020-08-28
ES2964146T3 (es) 2024-04-04
AU2017287746A1 (en) 2019-01-17
MX2018016361A (es) 2019-09-16
MX393450B (es) 2025-03-24
CN109476676A (zh) 2019-03-15
ZA201900121B (en) 2023-04-26
ES2929931T3 (es) 2022-12-05
US20210094967A1 (en) 2021-04-01
IL263826A (en) 2019-01-31
US11332475B2 (en) 2022-05-17
CA3028954A1 (en) 2018-01-04
US20190152984A1 (en) 2019-05-23
DK4023651T3 (da) 2023-11-20
SG11201811796SA (en) 2019-02-27
TWI731998B (zh) 2021-07-01
EP3480200A1 (en) 2019-05-08
CA3028954C (en) 2020-10-27
KR20180002539A (ko) 2018-01-08
WO2018004263A1 (ko) 2018-01-04
KR102388965B1 (ko) 2022-04-22
EP4023651B1 (en) 2023-09-13
AU2017287746B2 (en) 2020-04-09
JP2020186259A (ja) 2020-11-19
IL263826B1 (en) 2023-01-01
IL263826B2 (en) 2023-05-01

Similar Documents

Publication Publication Date Title
ZA201802125B (en) Pharmaceutical composition and application thereof
ZA201802003B (en) Dual function proteins and pharmaceutical composition comprising same
IL269061A (en) A pharmaceutical preparation containing Selexifag
EP3094343A4 (en) Rapid action insulin formulations and pharmaceutical delivery systems
EP3307265A4 (en) Pharmaceutical combination and uses thereof
EP3233111A4 (en) Pharmaceutical composition comprising plasminogen and uses thereof
DK3554534T3 (da) Farmaceutisk sammensætning omfattende insulin
ZA201900121B (en) Optically active pyranochromenyl phenol derivative and pharmaceutical composition comprising same
EP3297640A4 (en) Pharmaceutical co-crystal composition and use thereof
PT3202759T (pt) Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo
EP3285758A4 (en) Co-crystal composition and its pharmaceutical use
IL263040A (en) Pharmaceutical composition comprising eteplirsen
IL260321B (en) A multi-antigenic structure and a pharmaceutical preparation containing it
GB201406172D0 (en) Therapy and pharmaceutical composition
PT3302483T (pt) Composições farmacêuticas e seu uso
IL257621B (en) A catechol derivative and a pharmaceutical preparation that includes it
EP3497080A4 (en) PHARMACEUTICAL FORMULATIONS AND THEIR USE
ZA202000959B (en) Adamantylmethylamine derivative and use thereof as pharmaceutical
GB201519644D0 (en) Therapy and pharmaceutical composition
PL3424500T3 (pl) Kompozycja farmaceutyczna zawierająca famitynib
AP2017009706A0 (en) Pharmaceutical compound comprising 13 glycerides, formulation and application thereof
IL264083A (en) A pharmaceutical preparation containing benzydamine
HK40006816A (en) Pharmaceutical composition comprising eteplirsen
AU2015902260A0 (en) Pharmaceutical Combination and Uses Thereof
HK1236840B (en) Pharmaceutical composition comprising plasminogen and uses thereof